chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ADMINISTERED 2.5ML OF THE VACCINE; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 58 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, and batch number: 201A21A expiry: 21-SEP-2021) 2.5 ml, administered on 07-OCT-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-OCT-2021, the patient experienced administered 2.5ml of the vaccine. On 07-OCT-2021, the patient experienced off label use. The action taken with covid-19 vaccine was not applicable. The outcome of the administered 2.5ml of the vaccine and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to 20211220129, 20211220146, 20211220916, 20211220152, 20211219926, 20211165041, 20211200723, 20211200752, 20211200769, 20211201046, 20211201228, 20211201963, 20211202193, 20211202207, 20211202246, 20211202250, 20211202371, 20211165041, 20211200675, 20211200717, 20211200723, 20211201082, 20211200994, 20211201168, 20211201179, 20211201286, 20211201304, 20211201351, 20211201392, 20211201443, 20211201450, 20211201963, 20211202161, 20211202199, 20211219871, 20211220155 and 20211219681.
PT was very anxious about receiving the shot. Patient ate a muffin  and had water after receiving the vaccination. Patient started feeling tingling throughout the entire body, chest pain, and had difficulty breathing.   Symptoms resolved > Cleared by EMS and NP
Ringing in ears; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Dec2021 18:15 (Lot number: F516V) at the age of 54 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hemachromtosis knee replacement" (unspecified if ongoing), notes: Note: Hemachromtosis Knee replacement. Concomitant medication(s) included: INFLUENZA; LIPITOR; CLARITIN [LORATADINE]. Past drug history included: Known allergies: no, reaction(s): "Drug Allergy". Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, Batch/Lot No: EP7533, Location of injection: Arm Left), administration date: 09Apr2021, when the patient was 53 years old, for Covid-19 immunization; Bnt162b2 (DOSE 1, SINGLE, Batch/Lot No: EN6207, Location of injection: Arm Left), administration date: 17Mar2021, when the patient was 53 years old, for Covid-19 immunization. The following information was reported: TINNITUS (non-serious) with onset 13Dec2021 15:00, outcome "not recovered", described as "Ringing in ears". Therapeutic measures were not taken as a result of tinnitus.  No follow-up attempts are possible. No further information is expected.
She was Janssen COVID19 vaccine on 3/8/21.  She came in on 4/14/21 reporting that starting around 4/6/21 the injection arm started hurting. The pain was not localized to injection site and varied from the shoulder to the wrist and was on and off.  Could sometimes keep her up at night. She was advised per guidelines to contact her PCP.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, 2 days after receiving SHINGRIX, the patient experienced influenza-like symptoms, nausea, chills, pain and joint pain. On an unknown date, the outcome of the influenza-like symptoms, nausea, chills, pain and joint pain were recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms, nausea, chills, pain and joint pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. Few days ago, from the date of reporting, the patient received SHINGRIX and experienced flu-like symptoms, aching, joint pain, chills and nausea. The patient stated that if felt like he had severe case of the flu. The symptoms lasted for approximately 1 day. The reporter did not wish to provide any additional details. The patient wished to remain anonymous and did not wish to provide any additional details regarding the vaccine or event. This case has been linked with the case US2018195289 (patient's wife), reported by same reporter.
This spontaneous report was received from a nurse practitioner and refers to a female patient of unknown age. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported. The nurse practitioner reported that the patient received her first dose of GARDASIL 9 on 19-MAY-2016, her second dose of GARDASIL 9 on 28-JUL-2016, and her third dose of GARDASIL 9 on 30-AUG-2016 (lot numbers, expiration date, dose and route of administration were not provided); which was outside of the recommendations in the GARDASIL 9 prescribing information. No adverse effect was reported. Additional information is not expected as the reporter did not wish to be contacted.
This spontaneous report as received from a 46 year old female Medical Assistant reporting on herself. The patient had no pertinent medical history, drug reactions or concurrent conditions. On an unknown date, "during childhood", the patient was vaccinated with M-M-R II (albumin status HSA) subcutaneously. Dose, anatomical location, lot number and expiration date were not provided. No other suspect medications were reported and the patient did not have any concomitant medication. On an unknown date, in January 2014 the patient was performed a blood titer and showed that she was negative for mumps antibodies. Then, on an unknown date in March 2014, the patient was vaccinated with a second dose of M-M-R II subcutaneously. Dose, anatomical location, lot number and expiration date were not provided. And, on an unknown date, in April 2014, the patient was performed another blood titer and showed that she was positive for mumps antibodies. The outcome of the event was reported as recovered. The causality between the therapy with M-M-R II and the event was unknown. Additional information is not expected because there is no consent to contact the physician.
Pt expired 11 days after receiving vaccine. No indication his passing was related to the vaccine.  Narrative: No updated notes regarding cause of death. Patient's wife called to notify the facility of his passing on 1/26/2021
Vaccines administered on 10/9- pt states on 10/10, her arm began showing signs of redness, swelling, and tender to touch. I observed pt on 10/13 and effects were still present. Pt received rx for BACTRIM DS 1 po bid on 10/11 and KEFLEX 500 po q8h on 10/13.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 10-OCT-2012 11:20, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not provided. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0395AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Pt received smallpox vaccination around the 5th of February. She presented to sickcall 15 February with an itchy, maculopapular rash with no drainage on torso and on upper thighs.
12-20-04 MOTHER BROUGHT IN DTR. TO SHOW INDENTATION OF WHERE CHILD RECEIVED IMM. BACK IN JUNE. MOM STATED SITE BECAME SWOLLEN, RED, HARD KNOT, AFTER SWELLING WENT DOWN, SPOT BECAME VERY DRY THEN INDENTATION OCCURRED. SITE WAS L HIP AND MIDWAY TO L BUTTOCKS.  MOTHER STATED SITE BECAME REDDENED 06/21/2004.
This spontaneous report was received from a 41 year old male patient referring to himself. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX 0.65 ml, for prophylaxis (route of administration, lot # and expiration date were not reported). The patient was told that he needed to be vaccinated against chickenpox in order to work on a medical facility. It was stated that the patient's physician prescribed the vaccine.
Patient presented with word salad--concern for stroke--symptoms resolved about 45 mins after onset. will be admitted for TIA
Pt's reports "squiggly lines" in his vision, tingling of right upper lip, left temple headache, Right arm swelling. (vaccine was administered in Left arm)
Per patient she broke out in whelpts all over her body 2 days after the injection. Currently there is a reddish rash and scattered whelpts all over her body. Patient has pictures of diffused irritations and whelpts from when it first started. Denies wheezing, SOB, or taking any medications. Benadryl 25mg 1-2 caps Q 6hrs ordered for patient, if needed.
she noticed a weird lump near her collar bone.; This spontaneous case was reported by a patient and describes the occurrence of SKIN MASS (she noticed a weird lump near her collar bone.) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ETHINYLESTRADIOL, LEVONORGESTREL (SRONYX) for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 UNK. On an unknown date, the patient experienced SKIN MASS (she noticed a weird lump near her collar bone.). At the time of the report, SKIN MASS (she noticed a weird lump near her collar bone.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no treatment details reported.
24-48 hours after receiving dose, had low grade fever, headache, and malaise. On Tuesday morning (3 days after vaccine), woke up with vertigo, visual changes, severe nausea, diagnosed with cerebrovascular accident
Developed a rash on abdomen that was discovered at approximately 10 pm on 12/29/20, the day following the vaccination.  Personal physician diagnosed it the following day as shingles and an anti-viral (valacyclovir) was prescribed.  Last dose taken on 12/27/20.  Rash is clearing.
Hair loss diagnosed as scarring alopecia; began 30days after first dose. Atrial fibrillation: diagnosed first symptoms 30 days after first dose.
Eye is swollen; Eye is purple, Looks like black eye; Slight Itchy; Vision is blurred; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Eye is swollen), EYE COLOUR CHANGE (Eye is purple, Looks like black eye), EYE PRURITUS (Slight Itchy) and VISION BLURRED (Vision is blurred) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Pollen allergy and Gluten sensitivity.    On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced EYE SWELLING (Eye is swollen), EYE COLOUR CHANGE (Eye is purple, Looks like black eye), EYE PRURITUS (Slight Itchy) and VISION BLURRED (Vision is blurred). At the time of the report, EYE SWELLING (Eye is swollen), EYE COLOUR CHANGE (Eye is purple, Looks like black eye), EYE PRURITUS (Slight Itchy) and VISION BLURRED (Vision is blurred) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant or treatment information were not provided.
The past 2 menses have been short.  June 4th was a 24 day cycle--my cycles are usually 26-27 days, the menses lasted 6 days, which usually it lasts 3 days  July 16 was  a 18 day cycle --menses just started but super short cycle   Also I developed a folliculitis looking rash on my abdomen, legs, and arms. starting the week of 24June.  It still is present and has not gone away with steroids or clindamycin. it is red bumps, some pin point, some slightly bigger. they are widely dispersed. They do not itch or burn or have any sensation.
The health of my kidney has dramatically declined to the point to to where I would need to be put on dialysis. I was hospitalized for 5 days to keep testing for my kidney disease. I was on heparin, morphine, and other medications while being hospitalized.
A physician reported via manufacturer the inability of a 50 year old female to respond to the hepatitis B vaccine recombinant (Engerix-B) immunization series.  The subject's relevant medical history, concurrent conditions, and concurrent medications were not reported.  On unspecified dates, the subject received a series of Engerix-B injections.  Subsequently, she did not seroconvert.  As of 12/20/02, the outcome of the event was unknown.
Slight muscle soreness , fever of 102.5, weak, tired , slight nausea
The mother refers that after the vaccine was administered the child started to swell and afterward she had convulsions. After the episode the mother went directly to Dr., who is the pediatrician of the girl and made a referral to a neurologist, Dr., and to a geneticist, Dr.
Today has itchiness and redness like a rash/ itching bad all over, pretty bad, and is getting red kind of; Today has itchiness and redness like a rash/ itching bad all over, pretty bad, and is getting red kind of; Today has itchiness and redness like a rash/ itching bad all over, pretty bad, and is getting red kind of; This is a spontaneous report from a contactable consumer (patient). A 32-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: not reported) via an unspecified route of administration on 12Jul2021 as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization and did not experience any adverse event. Caller was calling about the Pfizer Covid-19 Vaccine, he stated he was calling about his symptoms, he had his second dose of the COVID-19 vaccine on yesterday (12Jul2021) and today (13Jul2021) had itchiness and redness like a rash, like he read on the paper of things that could happen. He would like to know how to slow this down or stop this reaction and also reported that he was itching bad all over, pretty bad, and is getting red kind of. The outcome of the events was unknown.  Information on lot/batch number has been requested.
Disseminated zoster, treated with IV acyclovir. Patient still hospitalized at time of this report.
Injection site pain and swelling Headache Fatigue Sore throat Lymph node swelling on neck Right ear pain
Patient developed numbness and weakness in left arm, left leg and left side of abdomen.  Cervical MRI with and without contrast showed enhancement . Lumbar puncture had high protein levels. Neurology consulted and think process is either cervical myelomalacia or cervical transverse myelitis/vaccine associated inflammation.  Patient had never had a problem like this before.  He was given high dose Solumedrol X 2 days and sent home on a prednisone taper.  His numbness and weakness had improved at time of discharge from the Hospital on May 18, 2021.  However, I see he has been readmitted to the Hospital on May 27, 2021 with similar symptoms.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1, (dose, lot # and expiry date unknown). On 20-MAY-2013, the patient receive improperly stored VARIVAX dose 2, from lot # 0610AE (dose, vaccination site, route, expiry date unknown). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
Big blood clots following Prostate Surgery 3 days after Vaccine applied  Please see attached explanation and pictures
Within a few hours, post vax, pt states arm became sore and red. At the time of the health dept's visit on 12/1/00, arm is inflammed 3" X 4" around injection site, warm to touch and slightly distended.
Pt received Moderna dose #1.   Pt experienced whate looked to be seizure and temprry loss of consciousness about 8-10 mins. into 15 min post-vaccine observe time.  Pt was gently placed on floor and legs elevated by staff   911 called.  EpiPen on hand, but not used as patient regained consciousness within 1 min or so and no c/o SOB, airway constriction - could verbalize same.   Pt lucid and conversational, but did ask "why am I on the floor" - no recollection of syncope or seizure.  No hx of seizure disorder, diabetes, or needle phobia, but states she did feel similar when naval piercing took place.
Redness around vaccinated area.  R arm 5.0 cm x 4.1 cm L arm 2.0 cm x 2.0 cm
My arm was sore, but not horrible. I was running a fever that day and evening, but then I developed a good sized headache and had exhaustion. The headaches lasted day and night for about 8-9 days straight. I am experiencing short term memory loss, tinnitus, vertigo, painful muscles/joints all over my body, dizziness, blurry vision. I'm also experiencing constant intolerance to foods. It's causing my hands and face to swell. I'm experiencing shortness of breath and unable to take a full breath.
Patient returned to pharmacy with painful to the touch, blackened/red bruised appearing area on skin over left tricep. Area was not hot to the touch but was approximately 4 inches by 3 inches in area.
Approximately 10 minutes post vax pt became sweaty and red around neck; heart pounding, and felt like she was going to pass out. Pt experienced shaking, trembling, facial numbness and tingling in ankles.
Extreme headaches, fever, chills, nausea, fatigue, diarrhea, body aches
Per report pt started to have SOB night of 8/1/21. During the day, 8/2/21 was not able to even eat. Started on 5L via NC, face was flushed, hadexternal cath because pt was unable to get out of bed. MD notified. CXR ordered, antibiotic given, BVG sent, breathing tx given twice, RT came and put pt on high flow at 45L 40%. Pt was getting Tachy, Md notified. This RN went to lunch and break RN called Rapid Response because pt c/o not able to stand the high flow. They tried to put pt on a face CPAP while waiting to transfer pt to ICU. Pt intubated in ICU
SOB, tachycardia, dizziness, headache - I did not alert a medical professional about my symptoms at the time.  I watched the clock knowing my wait time was 15 minutes hoping the symptoms would resolve within that time.  The SOB and tachycardia resolved in 20 minutes.  I had a headache and flu-like symptoms for 24 hrs.
Patient was talking after vaccine, once band-aid was applied pt looked unwell. I placed my hands behind him and he passed out. He opened his eyes and asked what happened. I had him lay down with his knees up and hand propped up. He said he felt very weak and that his vision was blurry and then he woke up. Offered pt juice and crackers as well as an ice pack. Had pt lay down for 30 mins rechecked vital signs all were normal. After pt sat up and moved to a chair he vomited x 1, Observed patient for about 20 more mins and once pt felt better he went home with parent.
At around 11:45 pm on 4/26/2017, I experienced chills and uncontrollable involuntary shaking until 12:05/12:10 am. Several parts of my body started twitching like my lower back, right hand, arms, shoulders and it was impossible to stay lying down. I noticed my jaw tightening and my speech a little constricted. The shaking increased with time and then stopped abruptly and completely.
Got the shot still got shingles/Suspected vaccination failure; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be possibly related to Shingrix.     Additional Information: GSK Receipt Date: 06-MAR-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient reported that she received Shingrix vaccine and still experienced Shingles. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Hallucination, chills, fever, lethargic, headache, foggy vision.  Patient still feels foggy as at 02/11/2022
Slight fever 3 days in a row; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Oct2021 (Lot number: FF8839) at the age of 67 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "High Blood Pressure" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL taken for hypertension; METOPROLOL TARTRATE taken for hypertension; TRIAMTERENE taken for hypertension. Vaccination history included: Bnt162b2 (Lot: Unknown, 1st dose), for COVID-19 immunisation; Bnt162b2 (Lot: Unknown, 2nd dose), for COVID-19 immunisation. The following information was reported: PYREXIA (non-serious) with onset 03Oct2021, outcome "not recovered", described as "Slight fever 3 days in a row". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia.  Additional information: Consumer stated, still experiencing the problem and took temperature at 8:15 tonight. Patient took Tylenol for 2 days in a row and don't know if took anything today. Patient got the Pfizer booster on Saturday and had a slight fever for like 3 days in a row now. Consumer confirmed the name of the product as Pfizer Covid19 vaccine.  Follow-up attempts completed. No further information expected.